Cardinal Health (NYSE: CAH), Dublin, OH, reported sales for the third quarter of $31.8 billion, an increase of 3.7 percent from the same period a year ago. Profit decreased 1 percent to $382 million.

Sales for the pharmaceutical segment increased 3.2 percent year-over-year to $28.4 billion, and profit decreased 7.4 percent to $611 million.

For the first nine months of the fiscal year, sales were $97 billion, a 7.6 percent increase from the previous year. Profit decreased 7.4 percent to $1 billion.